IMMUNOCELLULAR THERAPEUTICS's ticker is IMUCWS and the CUSIP is 452536113. A total of 3 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,077,000 | – | 15,161,641 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 9,375,000 | $1,106,000 | 0.12% |
| SABBY MANAGEMENT, LLC | 15,161,641 | $1,077,000 | 0.04% |
| UBS Group AG | 41,100 | $2,000 | 0.00% |